AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation

paclitaxel - Generic mfg.

AVA-NP-695 - Avammune

Lynparza (olaparib) - Merck (MSD), AstraZeneca

https://jitc.bmj.com/content/11/Suppl_1/A964

Avijit Goswami1; Sandeep Goyal2; Princy Khurana3; Kawaljit Singh3; Ishani Ghoshal1; Aditya Kulkarni3

Sep 27, 2023